Parenteral Nutrition (PN) Global Industry Outlook, 2030, by Nutrient, Stage, Indication, Sales Channel, and Region Featuring Braun Melsungen, Fresenius Kabi, and Allergan Among Others

DUBLIN, Aug. 21, 2023 /PRNewswire/ -- The "Global Parenteral Nutrition Market 2023-2030" report has been added to  ResearchAndMarkets.com's offering.

The global parenteral nutrition market is expected to reach USD 10.7 billion by 2030, registering a CAGR of 6% over the forecast period. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth.

However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. With the increasing population, healthcare costs and food expenditures for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition levels, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period.

In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8%, thereby boosting the demand for PN products worldwide. Furthermore, the presence of a large population base, aged above 60 years, suffering from low immunity levels, and prone to incidence of neurological diseases, cardiac problems, cancers, and spinal injuries, is a high-impact rendering driver for the parenteral lipid emulsions market over the forecast period. This population is expected to avail the latest surgical treatments, which is expected to increase their life span, thereby driving the need for intensive care & postoperative treatment, inclusive of PN products, such as lipid emulsions.

Parenteral Nutrition Market Report Highlights

• Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication.
• The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors
• Also, high infection rates, poor water quality & sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
• The single-dose amino acid solution nutrient type segment dominated the market in 2022 due to the introduction of newly available amino acid solutions with minimal side effects
• In 2022, the adult segment held the largest share due to increased adoption of parenteral nutrition products owing to the rising prevalence of various chronic diseases, such as Alzheimer's disease, sarcopenia, cancer, and diabetes among this age group
• The others indication segment dominated the market in 2022 due to the increased prevalence of Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatment, and other health ailments
• In 2022, institutional sales channels dominated the market owing to the high number of private & public healthcare institutions and the increased patient population with chronic disease
• North America dominated the global market in 2022 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Key Attributes

Key Topics Covered

Chapter 1. Methodology and Scope
1.1. Research Process
1.2. Information Procurement
1.3. Research Methodology
1.4. Research Scope and Assumptions
1.5. Research Methodology
1.6. List to Data Nutrient Type

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Parenteral Nutrition Market Snapshot

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. User Perspective Analysis
3.3. Regulatory Framework
3.4. Market Dynamics
3.5. Parenteral Nutrition Market Analysis Tools
3.6. Impact of COVID 19 on Parenteral Nutrition Market

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis
8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2022 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030

Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Key Company Market Position Analysis
9.3. Key Company Market Share Analysis
9.4. Recent Development and Impact Analysis, by key Market Participants
9.5. Company Profiles

• Braun Melsungen AG
• Fresenius Kabi AG
• Allergan
• Grifols SA
• Pfizer Inc.
• Otsuka Pharmaceutical Factory, Inc.
• Baxter
• Aculife
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Vifor Pharma

For more information about this report visit https://www.researchandmarkets.com/r/rmvj1a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets